214 related articles for article (PubMed ID: 10935492)
1. Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasion.
Crowe DL; Brown TN
Neoplasia; 1999 Oct; 1(4):368-72. PubMed ID: 10935492
[TBL] [Abstract][Full Text] [Related]
2. Jun N-terminal kinase 1 mediates transcriptional induction of matrix metalloproteinase 9 expression.
Crowe DL; Tsang KJ; Shemirani B
Neoplasia; 2001; 3(1):27-32. PubMed ID: 11326313
[TBL] [Abstract][Full Text] [Related]
3. A c-fos/Estrogen receptor fusion protein promotes cell cycle progression and proliferation of human cancer cell lines.
Crowe DL; Brown TN; Kim R; Smith SM; Lee MK
Mol Cell Biol Res Commun; 2000 Apr; 3(4):243-8. PubMed ID: 10891399
[TBL] [Abstract][Full Text] [Related]
4. Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression.
Murono S; Yoshizaki T; Sato H; Takeshita H; Furukawa M; Pagano JS
Cancer Res; 2000 May; 60(9):2555-61. PubMed ID: 10811139
[TBL] [Abstract][Full Text] [Related]
5. Regulation of matrix metalloproteinases (MMPs) expression and secretion in MDA-MB-231 breast cancer cells by LIM and SH3 protein 1 (LASP1).
Endres M; Kneitz S; Orth MF; Perera RK; Zernecke A; Butt E
Oncotarget; 2016 Sep; 7(39):64244-64259. PubMed ID: 27588391
[TBL] [Abstract][Full Text] [Related]
6. FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells.
Philips A; Teyssier C; Galtier F; Rivier-Covas C; Rey JM; Rochefort H; Chalbos D
Mol Endocrinol; 1998 Jul; 12(7):973-85. PubMed ID: 9658402
[TBL] [Abstract][Full Text] [Related]
7. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
Kutz SM; Providence KM; Higgins PJ
Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
[TBL] [Abstract][Full Text] [Related]
8. The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promoter activation.
Simon C; Simon M; Vucelic G; Hicks MJ; Plinkert PK; Koitschev A; Zenner HP
Exp Cell Res; 2001 Dec; 271(2):344-55. PubMed ID: 11716547
[TBL] [Abstract][Full Text] [Related]
9. A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers.
Bergman MR; Cheng S; Honbo N; Piacentini L; Karliner JS; Lovett DH
Biochem J; 2003 Feb; 369(Pt 3):485-96. PubMed ID: 12371906
[TBL] [Abstract][Full Text] [Related]
10. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades.
Gum R; Wang H; Lengyel E; Juarez J; Boyd D
Oncogene; 1997 Mar; 14(12):1481-93. PubMed ID: 9136992
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor/activated factor VIIa induces matrix metalloproteinase-7 expression through activation of c-Fos via ERK1/2 and p38 MAPK signaling pathways in human colon cancer cell.
Jia ZC; Wan YL; Tang JQ; Dai Y; Liu YC; Wang X; Zhu J
Int J Colorectal Dis; 2012 Apr; 27(4):437-45. PubMed ID: 22076613
[TBL] [Abstract][Full Text] [Related]
12. Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor.
Weisz A; Rosales R
Nucleic Acids Res; 1990 Sep; 18(17):5097-106. PubMed ID: 2119495
[TBL] [Abstract][Full Text] [Related]
13. Brain-derived neurotrophic factor induces matrix metalloproteinase 9 expression in neurons via the serum response factor/c-Fos pathway.
Kuzniewska B; Rejmak E; Malik AR; Jaworski J; Kaczmarek L; Kalita K
Mol Cell Biol; 2013 Jun; 33(11):2149-62. PubMed ID: 23508111
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro.
Lakka SS; Jasti SL; Gondi C; Boyd D; Chandrasekar N; Dinh DH; Olivero WC; Gujrati M; Rao JS
Oncogene; 2002 Aug; 21(36):5601-8. PubMed ID: 12165859
[TBL] [Abstract][Full Text] [Related]
15. Two proximal activating protein-1-binding sites are sufficient to stimulate transcription of the ovine follicle-stimulating hormone-beta gene.
Strahl BD; Huang HJ; Pedersen NR; Wu JC; Ghosh BR; Miller WL
Endocrinology; 1997 Jun; 138(6):2621-31. PubMed ID: 9165057
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the hormone-dependent regulation of a JunD-estrogen receptor chimera.
Francis MK; Phinney DG; Ryder K
J Biol Chem; 1995 May; 270(19):11502-13. PubMed ID: 7744790
[TBL] [Abstract][Full Text] [Related]
17. Induction of MMP-1 (collagenase-1) by relaxin in fibrocartilaginous cells requires both the AP-1 and PEA-3 promoter sites.
Kapila S; Xie Y; Wang W
Orthod Craniofac Res; 2009 Aug; 12(3):178-86. PubMed ID: 19627519
[TBL] [Abstract][Full Text] [Related]
18. Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells.
Shin WS; Hong Y; Lee HW; Lee ST
Oncotarget; 2016 Nov; 7(45):73242-73256. PubMed ID: 27689325
[TBL] [Abstract][Full Text] [Related]
19. Molecular Mechanism of Transcriptional Regulation of Matrix Metalloproteinase-9 in Diabetic Retinopathy.
Mishra M; Flaga J; Kowluru RA
J Cell Physiol; 2016 Aug; 231(8):1709-18. PubMed ID: 26599598
[TBL] [Abstract][Full Text] [Related]
20. Penta-O-galloyl-beta-D-glucose inhibits the invasion of mouse melanoma by suppressing metalloproteinase-9 through down-regulation of activator protein-1.
Ho LL; Chen WJ; Lin-Shiau SY; Lin JK
Eur J Pharmacol; 2002 Oct; 453(2-3):149-58. PubMed ID: 12398898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
